Helius Medical Technologies, Inc. (HSDT)
USD 0.38
(-6.0%)
USD 0.38
(-6.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 12 Thousand USD | -78.57% |
| 2022 | 56 Thousand USD | 0.0% |
| 2021 | - USD | -100.0% |
| 2020 | 32 Thousand USD | -93.12% |
| 2019 | 465 Thousand USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | - USD | 0.0% |
| 2024 Q1 | - USD | -100.0% |
| 2023 FY | 12 Thousand USD | -78.57% |
| 2023 Q2 | 35 Thousand USD | -23.91% |
| 2023 Q1 | 46 Thousand USD | -17.86% |
| 2023 Q3 | 23 Thousand USD | -34.29% |
| 2023 Q4 | 12 Thousand USD | -47.83% |
| 2022 Q3 | 70 Thousand USD | -15.66% |
| 2022 Q1 | 99 Thousand USD | 0.0% |
| 2022 FY | 56 Thousand USD | 0.0% |
| 2022 Q4 | 56 Thousand USD | -20.0% |
| 2022 Q2 | 83 Thousand USD | -16.16% |
| 2021 Q2 | - USD | -100.0% |
| 2021 Q3 | - USD | 0.0% |
| 2021 Q1 | 16 Thousand USD | -50.0% |
| 2021 FY | - USD | -100.0% |
| 2021 Q4 | - USD | 0.0% |
| 2020 FY | 32 Thousand USD | -93.12% |
| 2020 Q1 | 417 Thousand USD | -10.32% |
| 2020 Q2 | 62 Thousand USD | -85.13% |
| 2020 Q4 | 32 Thousand USD | -31.91% |
| 2020 Q3 | 47 Thousand USD | -24.19% |
| 2019 Q2 | 554 Thousand USD | -7.2% |
| 2019 Q1 | 597 Thousand USD | 0.0% |
| 2019 FY | 465 Thousand USD | 0.0% |
| 2019 Q4 | 465 Thousand USD | -9.0% |
| 2019 Q3 | 511 Thousand USD | -7.76% |
| 2018 Q3 | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 36.1 Million USD | 99.967% |
| BrainsWay Ltd. | 239 Thousand USD | 94.979% |
| Cerus Corporation | 59.79 Million USD | 99.98% |
| Envoy Medical, Inc. | 404 Thousand USD | 97.03% |
| electroCore, Inc. | 537 Thousand USD | 97.765% |
| IceCure Medical Ltd | 376 Thousand USD | 96.809% |
| Inogen, Inc. | 18.27 Million USD | 99.934% |
| OrthoPediatrics Corp. | 13.45 Million USD | 99.911% |
| Lucid Diagnostics Inc. | 199 Thousand USD | 93.97% |
| Monogram Orthopaedics, Inc. | 363.72 Thousand USD | 96.701% |
| MaxCyte, Inc. | 17.96 Million USD | 99.933% |
| NeuroOne Medical Technologies Corporation | 55.28 Thousand USD | 78.294% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| Orthofix Medical Inc. | 93.1 Million USD | 99.987% |
| PAVmed Inc | 2.96 Million USD | 99.595% |
| Rapid Micro Biosystems, Inc. | 6.21 Million USD | 99.807% |
| RxSight, Inc. | 1.21 Million USD | 99.009% |
| Sight Sciences, Inc. | 31.7 Million USD | 99.962% |
| SI-BONE, Inc. | 36.06 Million USD | 99.967% |
| TELA Bio, Inc. | 40.51 Million USD | 99.97% |
| Treace Medical Concepts, Inc. | 53 Million USD | 99.977% |
| Vivos Therapeutics, Inc. | 1.52 Million USD | 99.211% |
| Acutus Medical, Inc. | 32.65 Million USD | 99.963% |
| Talis Biomedical Corporation | 16.78 Million USD | 99.929% |
| Spectral AI, Inc. | - USD | -Infinity% |
| Nano-X Imaging Ltd. | 4.04 Million USD | 99.703% |
| CVRx, Inc. | 30.38 Million USD | 99.961% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 1.01 Million USD | 98.82% |
| Bioventus Inc. | 366.99 Million USD | 99.997% |
| Venus Concept Inc. | 70.79 Million USD | 99.983% |
| TriSalus Life Sciences, Inc. | 1.24 Million USD | 99.035% |
| LivaNova PLC | 568.54 Million USD | 99.998% |
| 908 Devices Inc. | 3.92 Million USD | 99.695% |
| Alphatec Holdings, Inc. | 511.03 Million USD | 99.998% |
| Nemaura Medical Inc. | 3.08 Million USD | 99.611% |
| NeuroPace, Inc. | 56.95 Million USD | 99.979% |
| LENSAR, Inc. | 1.75 Million USD | 99.314% |
| Apyx Medical Corporation | 33.18 Million USD | 99.964% |
| Cutera, Inc. | 418.69 Million USD | 99.997% |
| STRATA Skin Sciences, Inc. | 15.04 Million USD | 99.92% |
| BioSig Technologies, Inc. | 103 Thousand USD | 88.35% |
| Anika Therapeutics, Inc. | 26.9 Million USD | 99.955% |
| ClearPoint Neuro, Inc. | 9.94 Million USD | 99.879% |
| Integra LifeSciences Holdings Corporation | 1.48 Billion USD | 99.999% |
| Axonics, Inc. | 25.84 Million USD | 99.954% |
| Outset Medical, Inc. | 134.59 Million USD | 99.991% |
| IRIDEX Corporation | 1.75 Million USD | 99.315% |
| PROCEPT BioRobotics Corporation | 51.33 Million USD | 99.977% |
| IRadimed Corporation | 1.61 Million USD | 99.257% |
| Tivic Health Systems, Inc. | 176 Thousand USD | 93.182% |
| INVO Bioscience, Inc. | 6.77 Million USD | 99.823% |
| Telesis Bio, Inc. | 5.26 Million USD | 99.772% |
| Viemed Healthcare, Inc. | 5.97 Million USD | 99.799% |
| Varex Imaging Corporation | 464.2 Million USD | 99.997% |
| Quipt Home Medical Corp. | 60.82 Million USD | 99.98% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | 97.959% |
| Pulmonx Corporation | 35.08 Million USD | 99.966% |
| Dynatronics Corporation | 3.25 Million USD | 99.632% |
| Modular Medical, Inc. | 817 Thousand USD | 98.531% |
| ReShape Lifesciences Inc. | 151 Thousand USD | 92.053% |
| Semler Scientific, Inc. | 70 Thousand USD | 82.857% |
| InMode Ltd. | 6.61 Million USD | 99.819% |
| Bruker Corporation | 1.14 Billion USD | 99.999% |
| Cytosorbents Corporation | 2.54 Million USD | 99.528% |
| DexCom, Inc. | 2.57 Billion USD | 100.0% |
| Align Technology, Inc. | 96.96 Million USD | 99.988% |
| Viveve Medical, Inc. | 5.12 Million USD | 99.766% |
| ZimVie Inc. | 508.79 Million USD | 99.998% |
| Movano Inc. | 15.00 USD | -79900.0% |
| Cytek Biosciences, Inc. | 18.12 Million USD | 99.934% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 398.6 Million USD | 99.997% |
| Profound Medical Corp. | 4.97 Million USD | 99.759% |
| Insulet Corporation | 1.36 Billion USD | 99.999% |
| enVVeno Medical Corporation | 1.06 Million USD | 98.872% |
| Surmodics, Inc. | 29.4 Million USD | 99.959% |
| iCAD, Inc. | 273 Thousand USD | 95.604% |
| Nuwellis, Inc. | 221 Thousand USD | 94.57% |
| Biotricity, Inc. | 10.85 Million USD | 99.889% |
| iRhythm Technologies, Inc. | 34.95 Million USD | 99.966% |
| Aethlon Medical, Inc. | 649.75 Thousand USD | 98.153% |
| InspireMD, Inc. | 1.03 Million USD | 98.844% |
| PAVmed Inc. | 2.96 Million USD | 99.595% |
| BIOLASE, Inc. | 13.98 Million USD | 99.914% |
| Beyond Air, Inc. | 14.72 Million USD | 99.918% |
| FONAR Corporation | 37.92 Million USD | 99.968% |
| AxoGen, Inc. | 46.6 Million USD | 99.974% |
| Vivani Medical, Inc. | 19.31 Million USD | 99.938% |
| Tactile Systems Technology, Inc. | 44.61 Million USD | 99.973% |
| Inari Medical, Inc. | 30.35 Million USD | 99.96% |
| UFP Technologies, Inc. | 28 Million USD | 99.957% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 434.04 Thousand USD | 97.235% |
| Tenon Medical, Inc. | 428 Thousand USD | 97.196% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | 98.802% |
| Co-Diagnostics, Inc. | 2.15 Million USD | 99.442% |
| AdaptHealth Corp. | 2.09 Billion USD | 99.999% |
| Sintx Technologies, Inc. | 3.68 Million USD | 99.675% |
| NanoVibronix, Inc. | - USD | -Infinity% |
| Quanterix Corporation | 37.22 Million USD | 99.968% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | 97.959% |
| Sensus Healthcare, Inc. | 596 Thousand USD | 97.987% |
| Pacific Biosciences of California, Inc. | 892.24 Million USD | 99.999% |
| TransMedics Group, Inc. | 506.2 Million USD | 99.998% |
| ReWalk Robotics Ltd. | 607 Thousand USD | 98.023% |
| NeuroMetrix, Inc. | 92.48 Thousand USD | 87.025% |
| Hyperfine, Inc. | 64 Thousand USD | 81.25% |
| Establishment Labs Holdings Inc. | 188.73 Million USD | 99.994% |
| Biomerica, Inc. | 459 Thousand USD | 97.386% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | 97.33% |
| Bluejay Diagnostics, Inc. | 189.98 Thousand USD | 93.684% |
| Silk Road Medical, Inc | 75.62 Million USD | 99.984% |